Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-53 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
542678
Noden Pharma is a global specialty pharmaceutical company that is focused on acquiring prescription medicines.
- Karine Pinon: Chief Executive Officer
- Karine Pinon: CEO
About the Company
Noden Pharma is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a range of therapeutic areas. Noden Pharma DAC holds exclusive worldwide rights to manufacture, market and sell Tekturna® and Tekturna HCT® (or Rasilez® and Rasilez HTC® outside of the United States), which contain aliskiren, a
direct renin inhibitor, for the treatment of hypertension.
